SenesTech
Biotechnology · 1 employees
SenesTech is the rodent birth control expert and the only manufacturer of Rat Birth Control®, dedicated to improving global health by safely and humanely managing pest populations. Our product, Evolve™, disrupts reproduction in both male and female rats, using FIFRA Section 25(b) exempt soft baits that pose little to no risk to people, pets, wildlife, or the environment. As part of an Integrated P
Funding history
- Seed — $274K — Aug 2025
- Pre-Seed — $182K — Jul 2025
- Seed — $1.5M — Apr 2023
- Series C — Undisclosed — Aug 2022
- Venture - Series Unknown — $10.0M — Feb 2021
Recent signals
- May 07, 2026: SenesTech Appoints Michael Edell as President and Chief Executive Officer
- Aug 12, 2025: Raised $274K in Seed
- Jul 14, 2025: Raised $182K in Pre-Seed
- Oct 31, 2024: Launched SenesTech, Inc. announces the registration of Evolve™ in Hong Kong, offering a humane rodent control solution.
- Apr 26, 2023: Raised $1.5M in Seed
- Aug 26, 2022: Raised funding in Series C
- Feb 10, 2021: Raised $10.0M in Venture - Series Unknown
- Nov 10, 2020: Raised $3.1M in Venture - Series Unknown
See plans & pricing → Track SenesTech’s funding, hiring, and signals — with verified contacts — on Fundz.